Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 123

1.

Genome mining identifies cepacin as a plant-protective metabolite of the biopesticidal bacterium Burkholderia ambifaria.

Mullins AJ, Murray JAH, Bull MJ, Jenner M, Jones C, Webster G, Green AE, Neill DR, Connor TR, Parkhill J, Challis GL, Mahenthiralingam E.

Nat Microbiol. 2019 Mar 4. doi: 10.1038/s41564-019-0383-z. [Epub ahead of print]

PMID:
30833726
2.

Beware biofilm! Dry biofilms containing bacterial pathogens on multiple healthcare surfaces; a multi-centre study.

Ledwoch K, Dancer SJ, Otter JA, Kerr K, Roposte D, Rushton L, Weiser R, Mahenthiralingam E, Muir DD, Maillard JY.

J Hosp Infect. 2018 Nov;100(3):e47-e56. doi: 10.1016/j.jhin.2018.06.028. Epub 2018 Jul 17.

PMID:
30026003
3.

The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial.

Ronchetti K, Tame JD, Paisey C, Thia LP, Doull I, Howe R, Mahenthiralingam E, Forton JT.

Lancet Respir Med. 2018 Jun;6(6):461-471. doi: 10.1016/S2213-2600(18)30171-1. Epub 2018 May 16.

4.

The consistent differential expression of genetic pathways following exposure of an industrial Pseudomonas aeruginosa strain to preservatives and a laundry detergent formulation.

Green AE, Amézquita A, Le Marc Y, Bull MJ, Connor TR, Mahenthiralingam E.

FEMS Microbiol Lett. 2018 May 1;365(9). doi: 10.1093/femsle/fny062.

5.

Molecular epidemiology of Pseudomonas aeruginosa in an unsegregated bronchiectasis cohort sharing hospital facilities with a cystic fibrosis cohort.

Mitchelmore PJ, Randall J, Bull MJ, Moore KA, O'Neill PA, Paszkiewicz K, Mahenthiralingam E, Scotton CJ, Sheldon CD, Withers NJ, Brown AR.

Thorax. 2017 Aug 26. pii: thoraxjnl-2016-209889. doi: 10.1136/thoraxjnl-2016-209889. [Epub ahead of print]

PMID:
28844058
6.

Evidence of persistence of Prevotella spp. in the cystic fibrosis lung.

Gilpin DF, Nixon KA, Bull M, McGrath SJ, Sherrard L, Rolain JM, Mahenthiralingam E, Elborn JS, Tunney MM.

J Med Microbiol. 2017 Jun 13. doi: 10.1099/jmm.0.000500. [Epub ahead of print]

PMID:
28604331
7.

Discovery and Biosynthesis of Gladiolin: A Burkholderia gladioli Antibiotic with Promising Activity against Mycobacterium tuberculosis.

Song L, Jenner M, Masschelein J, Jones C, Bull MJ, Harris SR, Hartkoorn RC, Vocat A, Romero-Canelon I, Coupland P, Webster G, Dunn M, Weiser R, Paisey C, Cole ST, Parkhill J, Mahenthiralingam E, Challis GL.

J Am Chem Soc. 2017 Jun 14;139(23):7974-7981. doi: 10.1021/jacs.7b03382. Epub 2017 Jun 5.

8.

Reclassification of the Specialized Metabolite Producer Pseudomonas mesoacidophila ATCC 31433 as a Member of the Burkholderia cepacia Complex.

Loveridge EJ, Jones C, Bull MJ, Moody SC, Kahl MW, Khan Z, Neilson L, Tomeva M, Adams SE, Wood AC, Rodriguez-Martin D, Pinel I, Parkhill J, Mahenthiralingam E, Crosby J.

J Bacteriol. 2017 Jun 13;199(13). pii: e00125-17. doi: 10.1128/JB.00125-17. Print 2017 Jul 1.

9.

Burkholderia: an update on taxonomy and biotechnological potential as antibiotic producers.

Depoorter E, Bull MJ, Peeters C, Coenye T, Vandamme P, Mahenthiralingam E.

Appl Microbiol Biotechnol. 2016 Jun;100(12):5215-29. doi: 10.1007/s00253-016-7520-x. Epub 2016 Apr 26. Review.

PMID:
27115756
10.

Phenotypic characterization of an international Pseudomonas aeruginosa reference panel: strains of cystic fibrosis (CF) origin show less in vivo virulence than non-CF strains.

Cullen L, Weiser R, Olszak T, Maldonado RF, Moreira AS, Slachmuylders L, Brackman G, Paunova-Krasteva TS, Zarnowiec P, Czerwonka G, Reilly J, Drevinek P, Kaca W, Melter O, De Soyza A, Perry A, Winstanley C, Stoitsova SR, Lavigne R, Mahenthiralingam E, Sá-Correia I, Coenye T, Drulis-Kawa Z, Augustyniak D, Valvano MA, McClean S.

Microbiology. 2015 Oct;161(10):1961-77. doi: 10.1099/mic.0.000155. Epub 2015 Aug 6.

PMID:
26253522
11.

Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis.

Flight WG, Smith A, Paisey C, Marchesi JR, Bull MJ, Norville PJ, Mutton KJ, Webb AK, Bright-Thomas RJ, Jones AM, Mahenthiralingam E.

J Clin Microbiol. 2015 Jul;53(7):2022-9. doi: 10.1128/JCM.00432-15. Epub 2015 Apr 15.

12.

Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years' experience.

Zlosnik JE, Zhou G, Brant R, Henry DA, Hird TJ, Mahenthiralingam E, Chilvers MA, Wilcox P, Speert DP.

Ann Am Thorac Soc. 2015 Jan;12(1):70-8. doi: 10.1513/AnnalsATS.201408-395OC.

PMID:
25474359
13.

The domestication of the probiotic bacterium Lactobacillus acidophilus.

Bull MJ, Jolley KA, Bray JE, Aerts M, Vandamme P, Maiden MC, Marchesi JR, Mahenthiralingam E.

Sci Rep. 2014 Nov 26;4:7202. doi: 10.1038/srep07202.

14.

Emerging cystic fibrosis pathogens and the microbiome.

Mahenthiralingam E.

Paediatr Respir Rev. 2014 Jun;15 Suppl 1:13-5. doi: 10.1016/j.prrv.2014.04.006. Epub 2014 Apr 13. Review.

PMID:
24832700
15.

Evaluation of five selective media for the detection of Pseudomonas aeruginosa using a strain panel from clinical, environmental and industrial sources.

Weiser R, Donoghue D, Weightman A, Mahenthiralingam E.

J Microbiol Methods. 2014 Apr;99:8-14. doi: 10.1016/j.mimet.2014.01.010. Epub 2014 Jan 25.

PMID:
24472675
16.

Arabidopsis thaliana and Pisum sativum models demonstrate that root colonization is an intrinsic trait of Burkholderia cepacia complex bacteria.

Vidal-Quist JC, O'Sullivan LA, Desert A, Fivian-Hughes AS, Millet C, Jones TH, Weightman AJ, Rogers HJ, Berry C, Mahenthiralingam E.

Microbiology. 2014 Feb;160(Pt 2):373-84. doi: 10.1099/mic.0.074351-0. Epub 2013 Dec 10.

PMID:
24327425
17.

Developing an international Pseudomonas aeruginosa reference panel.

De Soyza A, Hall AJ, Mahenthiralingam E, Drevinek P, Kaca W, Drulis-Kawa Z, Stoitsova SR, Toth V, Coenye T, Zlosnik JE, Burns JL, Sá-Correia I, De Vos D, Pirnay JP, Kidd TJ, Reid D, Manos J, Klockgether J, Wiehlmann L, Tümmler B, McClean S, Winstanley C; EU FP7 funded COST Action BM1003 “Cell surface virulence determinants of cystic fibrosis pathogens”.

Microbiologyopen. 2013 Dec;2(6):1010-23. doi: 10.1002/mbo3.141. Epub 2013 Nov 11.

18.

Growth on mannitol-rich media elicits a genome-wide transcriptional response in Burkholderia multivorans that impacts on multiple virulence traits in an exopolysaccharide-independent manner.

Denman CC, Robinson MT, Sass AM, Mahenthiralingam E, Brown AR.

Microbiology. 2014 Jan;160(Pt 1):187-97. doi: 10.1099/mic.0.072975-0. Epub 2013 Nov 6.

PMID:
24196427
19.

The life history of Lactobacillus acidophilus as a probiotic: a tale of revisionary taxonomy, misidentification and commercial success.

Bull M, Plummer S, Marchesi J, Mahenthiralingam E.

FEMS Microbiol Lett. 2013 Dec;349(2):77-87. doi: 10.1111/1574-6968.12293. Epub 2013 Oct 24.

20.

The effect of cationic microbicide exposure against Burkholderia cepacia complex (Bcc); the use of Burkholderia lata strain 383 as a model bacterium.

Knapp L, Rushton L, Stapleton H, Sass A, Stewart S, Amezquita A, McClure P, Mahenthiralingam E, Maillard JY.

J Appl Microbiol. 2013 Nov;115(5):1117-26. doi: 10.1111/jam.12320. Epub 2013 Sep 3.

Supplemental Content

Loading ...
Support Center